The 10th International Pharmaceutical High Technology & Industrialization Development Summit will be elaborately held on Sep 18th-21st, 2012, at Suzhou，Taicang by China Pharmaceutical Technology Transfer Center, China Pharmaceutical Industry Technology Promotion Organization, which is a top platform to gather domestic and overseas new drug R&D resources, to promote advanced technology, key technology, and core technology of industrialization. With the support of Ministry of Science and Technology, Ministry of Health and State Food and Drug Administration, local government, etc, it has enjoyed good reputation at home and abroad..
At that time, there are nearly 50 top experts from domestic and overseas pharmaceutical field and officials from National Development and Reform Commission, Ministry of Science and Technology and State Food and Drug Administration to give us splendid reports around progress of new drug advanced technology at home and abroad, Chinese pharmaceutical industry and regulatory affair. Also, there are several top project-docking discussions. It is estimated that almost 500 delegates will attend this summit from domestic and overseas Pharmaceutical Corporation, new drug R&D institute, investment and financing institute, CRO and other related organizations. Detail agenda is below:
1. TIME AND PLACE
a) Time: Sep 18th-21st, 2012
b) Place: Four Points by Sheraton Taicang, Suzhou
2. ORGANIZATION
3. AGENDA
8:30 – 17:30 Tuesday, September 18, 2012
Registration
8:30 – 12:00 Wednesday, September 19, 2012
Keynote Speech
Strategies for pharmaceutical industry development and innovation of new drugs in China
Prof. Guowei SANG
Vice Chairman of the National People’s Congress
Chairman of the Chinese Pharmaceutical Association
Academician of the Chinese Academy of Engineering
To promote innovation and industrialization of new drugs by development of GRP in China
Mr. Wei ZHANG
Director of Department of Drug Registration, SFDA
To promote industrialization of major new drug projects by strengthening the dominant position of enterprises in innovation
Ministry of Science and Technology, China
To master the core technologies and to enhance the independent abilities biomedicine industry in China
Department of High-Tech Industry, National Development and Reform Commission
Open innovation and technology transfer of significant drug by multi-national pharmaceutical enterprises
Speaker from Eli Lilly
EU and US regulatory requirement for biosimilars
Dr. Zak Huang
Director of Worldwide Regulatory Affairs, Merck (MSD)
12:00 – 13:15
Lunch Break
Symposium 1 Technological forefront of new chemical drugs R&D
13:30 – 15:00
Technological forefront in the discovery of leading compounds and new drug targets
Dr. Jingkang SHEN
Director of the Chinese Academy of Sciences, Shanghai Pharmaceutical Institute
Application of asymmetric reaction in the synthesize of chiral drugs
Prof. Fen’er CHEN
Department of Chemistry, the Fudan University
R&D of new drugs for the targeted therapy of neurodegenerative disease
Dr. Xiangping QIAN
CEO, Suzhou NeuPharma Co., Ltd.
15:00 – 15:30
Break
15:30 – 16:30
Two speakers are going to be confirmed
16:30 – 17:30
Panel discussion
Symposium 2
Technological forefront and internationalization of TCM/natural drugs R&D
13:30 – 15:00
Quality evaluation of innovative drugs R&D from TCM
Prof. Ruichao LIN
Director of Institute for Control of Chinese Traditional Medicine and Ethnic Medicine, National Institutes for food and drug Control (NIFDC)
Discovery and R&D of new drugs based on the concept of natural pharmacy
Prof. Renbing SHI
Vice dean of Chinese Materia Medica School, Beijing University of Chinese Medicine
New technologies and new trends in the new drug R&D of TCM internationalization
Prof. Yitao WANG
Institute of Chinese Medicine Science, the University of Macau
15:00 – 15:30
Break
15:30 – 16:30
Innovative R&D of TCM
Prof. Hongxi XU
Vice dean of Chinese Materia Medica School,
Shanghai University of Traditional Chinese Medicine
Internationalization of quality standards of Chinese medicine---a case analysis of ‘Diao Xinxuekang’
Dr. Jianxin JI
Director of Institute of Metaria Medica, Diao Group
16:30 – 17:30
Panel discussion
Symposium 3 Technological forefront of Biopharmaceutical R&D
13:30 – 15:00
The trends and progress of R&D on Biotechnological drugs
Mr. Xinliang SHEN
Deputy General Manager, China National Biotec Group
Research of human monoclonal antibody targeting therapy of tumor
Prof. Zhihua YANG
Cancer Instisute, Chinese Academy of Medical Sciences
The establishment and application of key technologies research platform for nucleic acid drug
Prof. Shengqi WANG
Institute of Radiation Medicine, Academy of Military Medical Sciences
15:00 – 15:30
Break
15:30 – 16:30
Complex structural analysis of recombinant protein drugs
Prof. Kaihua WEI
Director of Peptidomics Lab, the Beijing Proteomics Research Center
Therapeutic vaccines for cervical cancer
Taiwan ShengBao Biotechnology Co., Ltd.
16:30 – 17:30
Panel discussion
Thursday, September 20, 2012
Symposium 4
Technology forefront of Translational Medicine and new drug R&D
8:30 – 10:00
The current status and the prospect of antibody drugs for tumor immunotherapy
Prof. Zonghai LI
Shanghai Cancer Institute
R&D of one new therapy for cancer based on activated dendritic cells
Libor Taborsky
CEO, SOTIO Medical Research Co., Ltd. Czech Republic
Effective screening of biomarkers by omics technology with high throughput
Dr. Huasheng XIAO
Managing Director of Shanghai Biochip Co., Ltd.
10:00 – 10:30
Break
10:30 – 11:30
Identification of biomarkers in the R&D of new drug
Dr. Danyi WEN
Senior Vice President, Shanghai ChemPartner Co., Ltd.
One speaker to be confirmed
11:30 – 12:00
Panel discussion
12:00 – 13:15
Lunch Break
Symposium 5
Technological forefront of Manufacture and the quality improvement of drug
(The co- organizers: Shanghai Henlius Biotech Co. Ltd., Beijing Canny Consulting Inc.）
8:30 – 10:00
The quality standards of the recombinant protein drug during "The 12th Five Years-Plan”
Ms. Qi SHEN
Director of Department of Biological Products, the National Institutes for Food and Drug Control
The quality standards management of drug based on new pharmacopoeia
Mr. Ping WANG
Deputy Secretary-General,Pharmacopoeia Commission of China
Drug safety Regulatory of biological products under the new GMP
Speaker to be confirmed
Center for Certification of Drug, the State Food and Drug Administration
10:00 – 10:30
Break
10:30 – 11:30
New GMP for certification and certification points from GMP of Europe and the United States
Mr. Pengcheng KANG
Chairman of the board, Beijing Canny Consulting Inc.
The international application trend of single use manufacturing system
Mr. Jerold Martin
Chairman,The Bio-Process Systems Alliance
11:30 – 12:00
Panel discussion
12:00 – 13:15
Lunch Break
4. Project Cooperation Communicating and Negotiating
Thursday, September 20, 2012
13:30-15:30
1) project referrals and road shows (domestic and overseas)
Trough live project referrals, road shows, project introductions, materials, project releasing, negotiations and other ways; practical, innovative and mature new drug technology projects are screened to promote new drug technology transfer and commercialization cooperation at home and abroad.
2) Special docking activities of regional medicine industry
During this summit, project docking will carry out for local bio-pharmaceutical industry development, corporate technology innovation requirements, technology transfer or cooperation requirement of new drug R&D organization.
3) Project introduction meeting for Bio-pharmaceutical Park
During this summit, some docking activities will be hold for international technology transfer projects, talent returnees, transnational pharmaceutical companies and Bio-pharmaceutical Parks, which can meet the investment demand of Bio-pharmaceutical Parks, incubators, industrialization base. (Hot and limited!)
5. TARGET AUDIENCE
1) Domestic and overseas pharmaceuticals groups, drug manufacturing enterprises, technology managers who are responsible for R&D and technology
2) Domestic and overseas research institutes, new drug R&D institutes, national key laboratories, managers and technical staff from universities, drug departments, medicine department, biology department
3) Executives and project leaders from new drug R&D enterprises and technology service institutes at home and abroad
4) Executives and project leaders from new drug R&D, investment, technology transfer and industrialization promotion institutes, which include Pharmaceutical Industry Park, incubator, investment organization, company, medical institutes, technology agency, etc.
6. COOPERATION OPPORTUNITIES
1) Speech and Exchange
There are special chances at this summit for drug manufacturing enterprises, R&D institutes, CRO institutes, etc. Welcome to recommend appropriate topics and experts related our summit.
2) Project referral and releasing
There are live project referrals for optimized projects, and international project is preferred (approximately 10-15mins). This is a book of project compilation for participants about project transfer and requirement.
3) Display platform
Platform for product, technology, service is provided; both parties can discuss the cooperation issue.
7. Links about Suzhou
http://en.wikipedia.org/wiki/Suzhou
http://www.classicsuzhou.com/Default.aspx
http://www.chinahighlights.com/suzhou/
8. PAYMENT
3200 RMB or $500 per person, which includes registration, conference meal, material and travel.
9. CONTACT US
1. China Pharmaceutical Technology Transfer Center (CPTTC) Beijing
Add: Tower A, 20th floor, Top Building, No.3 Haidian Street, Zhangguancun, Beijing, China
Tel: +86 10-51665863 ext858 Fax: +86 10-8269 8525
Contact person: Hui Zhang
E-mail：forum@pharmtec.org.cn
Website：http://www.pharmtec.org.cn/hitech2012/
2. Shanghai branch center
Add：Fengxian Bio-tech Park, No. 588 Jinhai Road, Shanghai
Tel: +8621 37195217、37195801 Fax: +8621 37195217
Contact person: Lei Peng
E-mail：fxbiotech@pharmtec.org.cn
The 10th International Pharmaceutical Advanced Technology & Industrialization Development Summit
Registration Form
|
|
|
Company
|
|
Mobile No.
|
|
|
Add
|
|
Postcode
|
|
|
Contact person
|
|
Position
|
|
|
Tel/Fax
|
|
E-mail
|
|
|
Participants
|
|
|
Name
|
Gender
|
Department and Position
|
E-mail
|
Mobile No.
|
|
1
|
|
|
|
|
|
|
2
|
|
|
|
|
|
|
3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hotel information:
http://www.starwoodhotels.com/fourpoints/property/overview/index.html?EM=VTY_FP_3377_TAICANG_PROP_OVERVIEW&propertyID=3377&language=en_US&localeCode=en_US
Please email us this form to forum＠pharmtec.org.cn
Website: http://www.pharmtec.org.cn/hitech2012/